These 3 healthcare stocks should come to life as boomers live their golden years

Baby boomers: Love ‘em or hate ‘em, the juggernaut generation changes every aspect of life it steamrolls through. Now it’s doing the same to healthcare. By 2030, every baby boomer will be 65 or older. Many will live well into their 80s, given that a 65-year-old currently can expect to live 18 more years.

Healthcare plays look particularly cheap right now because investors despise biopharma stocks. “Sector sentiment feels pretty close to an all-time low,” Baird biotech analyst Brian Skorney reports. Here are three timely health care stocks that reflect this theme — two that company insiders favor and one from Morningstar Direct, which does solid stock research.This drug maker is particularly strong in therapies for ailments that affect the elderly — including cancer, cardiovascular disease and diabetes. AstraZeneca’s AZN, -0.46% biggest business is cancer therapies. The company derives about 39% of its revenue from this area.

Another bullish factor: The company gets just 41% of its revenue from U.S. sales. This limits the potential impact of government price controls to some degree. Conover also assigns AstaZeneca a wide moat based on its patents and distribution network.If you know anyone who has gotten a hip or knee replacement, the chances are good they are now walking with help from a Zimmer Biomet ZBH, -1.17% product. The company makes orthopedic reconstructive products, mainly for knee and hip replacement.

“It’s early innings, frankly, both for ROSA as well as cementless,” CEO Ivan Tornos said on the latest earnings call. The Persona OsseoTi Keel Tibia launch has been hit by supply issues which will be resolved early in the first quarter of 2024, he says.In the current sell off, a cluster of Zimmer Biomet insiders purchased about $700,000 worth of stock in the $112-$120 range. Cluster-buys are a positive signal in insider analysis.

This is one reason that STAAR Surgical has been guiding down on growth, which has hurt the stock. But the new guidance is not terrible. The company expects to post 20% sales growth this year. “We believe we will continue to be a high-growth company beyond 2023 in the 15% to 20% range,” CEO Tom Frinzi says.

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

Stock Market Today: Dow, S&P 500 Open Lower; Alphabet Stock Price FallsLive updates on what's moving markets, including stocks the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite
Источник: WSJ - 🏆 98. / 63 Прочитайте больше »

Stock Market News Today: Dow, Nasdaq Slip; Alphabet Stock Price FallsLive updates on what's moving markets, including stocks the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite
Источник: WSJ - 🏆 98. / 63 Прочитайте больше »

Google’s ad business beat expectations but Cloud miss knocks stock in after-hours tradingGoogle released its Q3 earnings on Tuesday that largely beat Wall Street's expectations, although a miss on cloud revenue sent its stock sliding in after hours trading.
Источник: FoxBusiness - 🏆 458. / 53 Прочитайте больше »

Hong Kong Cuts Housing, Stock-Market Taxes in Bid to Boost Global Standing -- UpdateBy Ben Otto Hong Kong will cut taxes on home purchases and stock trades, part of efforts to revive its credentials as a financial hub and boost a struggling...
Источник: MarketWatch - 🏆 3. / 97 Прочитайте больше »

Analysis: China holds the key to Hong Kong's shrinking stock marketHong Kong's efforts to revive its shrinking stock market are mere stopgap solutions, as analysts say a reversal in fortunes for Asia's premier financial hub would not be possible without a major improvement in China's economic prospects.
Источник: Reuters - 🏆 2. / 97 Прочитайте больше »